Comparison of serum carnitine levels and clinical correlates between outpatients and acutely hospitalised individuals with bipolar disorder and schizophrenia: A cross-sectional study

References

• Abdul HM, Butterfield DA. 2007. Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. Free Radic Biol Med. 42:371–384.
   PubMed Web of Science ®Google Scholar
• Angelini C, Vergani L, Martinuzzi A. 1992. Clinical and biochemical aspects of carnitine deficiency and insufficiency: transport defects and inborn errors of beta-oxidation. Crit Rev Clin Lab Sci. 29:217–242.
   PubMed Web of Science ®Google Scholar
• Binienda Z, Przybyla-Zawislak B, Virmani A, Schmued L. 2005. L-carnitine and neuroprotection in the animal model of mitochondrial dysfunction. Ann N Y Acad Sci. 1053:174–182.
   PubMed Web of Science ®Google Scholar
• Breningstall GN. 1990. Carnitine deficiency syndromes. Pediatr Neurol. 6:75–81.
   PubMed Web of Science ®Google Scholar
• Callaly E, Walder K, Morris G, Maes M, Debnath M, Berk M. 2015. Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy. Mini Rev Med Chem. 15:355–365.
   PubMed Web of Science ®Google Scholar
• Cuturic M, Abramson RK, Moran RR, Hardin JW. 2010. Clinical outcomes and low-dose levocarnitine supplementation in psychiatric inpatients with documented hypocarnitinemia: a retrospective chart review. J Psychiatr Pract. 16:5–14.
   PubMed Web of Science ®Google Scholar
• Cuturic M, Abramson RK, Moran RR, Hardin JW, Hall AV. 2011. Clinical correlates of low serum carnitine levels in hospitalized psychiatric patients. World J Biol Psychiatry. 12:73–79.
   PubMed Web of Science ®Google Scholar
• Cuturic M, Abramson RK, Moran RR, Hardin JW. 2011. Carnitine and metabolic correlates in hospitalized psychiatric patients: a follow-through report. J Psychiatr Pract. 17:35–40.
   PubMed Web of Science ®Google Scholar
• Dealberto MJ. 2007. Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting. Int Clin Psychopharmacol. 22:330–337.
   PubMed Web of Science ®Google Scholar
• Evans AM, Fornasini G. 2003. Pharmacokinetics of L-carnitine. Clin Pharmacokinet. 42:941–967.
   PubMed Web of Science ®Google Scholar
• Fan J, Ionita-Laza I, McQueen MB, Devlin B, Purcell S, Faraone SV, Allen MH, Bowden CL, Calabrese JR, Fossey MD, et al. 2010. Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I disorder susceptibility locus. Am J Med Genet B Neuropsychiatr Genet. 153:29–37.
   Google Scholar
• Fouque D, Holt S, Guebre-Egziabher F, Nakamura K, Vianey-Saban C, Hadj-Aïssa A, Hoppel CL, Kopple JD. 2006. Relationship between serum carnitine, acylcarnitines, and renal function in patients with chronic renal disease. J Ren Nutr. 16:125–131.
   PubMed Web of Science ®Google Scholar
• Gan X, Wu L, Huang S, Zhong C, Shi H, Li G, Yu H, Howard Swerdlow R, Xi Chen J, Yan S. 2014. Oxidative stress-mediated activation of extracellular signal-regulated kinase contributes to mild cognitive impairment-related mitochondrial dysfunction. Free Radic Biol Med. 75:230–240.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant D. 2004. Definition of metabolic syndrome: report of the National, Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 109:433–438.
   PubMed Web of Science ®Google Scholar
• Gubert C, Stertz L, Pfaffenseller B, Panizzutti BS, Rezin GT Massuda R, Streck EL, Gama CS, Kapczinski F, Kunz M. 2013. Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects. J Psychiatr Res. 47:1396–1402.
   PubMed Web of Science ®Google Scholar
• Hsu CC, Chuang YH, Tsai JL, Jong HJ, Shen YY, Huang HL, Chen HL, Lee HC, Pang CY, Wei YH, et al. 1995. CPEO and carnitine deficiency overlapping in MELAS syndrome. Acta Neurol Scand. 92:252–255.
   PubMed Web of Science ®Google Scholar
• Laub MC, Paetzke-Brunner I, Jaeger G. 1986. Serum carnitine during valproic acid therapy. Epilepsia. 27:559–562.
   PubMed Web of Science ®Google Scholar
• Lheureux PE, Penaloza A, Zahir S, Gris M. 2005. Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence? Crit Care. 9:431–440.
   PubMed Web of Science ®Google Scholar
• Longo N, Amat di San Filippo C, Pasquali M. 2006. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet. 142C:77–C85.
   PubMed Web of Science ®Google Scholar
• Moreno FA, Macey H, Schreiber B. 2005. Carnitine levels in valproic acid-treated psychiatric patients: a cross-sectional study. J Clin Psychiatry. 66:555–558.
   PubMed Web of Science ®Google Scholar
• Nugent KL, Chiappelli J, Rowland LM, Hong LE. 2015. Cumulative stress pathophysiology in schizophrenia as indexed by allostatic load. Psychoneuroendocrinology. 60:120–129.
   PubMed Web of Science ®Google Scholar
• Ohtani Y, Endo F, Matsuda I. 1982. Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr. 101:782–785.
   PubMed Web of Science ®Google Scholar
• Pons R, De Vivo DC. 1995. Primary and secondary carnitine deficiency syndromes. J Child Neurol. 10:8–24.
   Web of Science ®Google Scholar
• Rajasekaran A, Venkatasubramanian G, Berk M, Debnath M. 2015. Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications. Neurosci Biobehav Rev. 48:10–21.
   PubMed Web of Science ®Google Scholar
• Rebouche CJ. 2004. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci. 1033:30–41.
   PubMed Web of Science ®Google Scholar
• Scaglia F, Wang Y, Singh RH, Dembure PP, Pasquali M, Fernhoff PM, Longo N. 1998. Defective urinary carnitine transport in heterozygotes for primary carnitine deficiency. Genet Med. 1:34–39.
   PubMed Web of Science ®Google Scholar
• Takiyama N, Matsumoto K. 1998. Age-and sex-related differences of serum carnitine in a Japanese population. J Am Coll Nutr. 17:71–74.
   PubMed Web of Science ®Google Scholar
• Tolu P, Masi F, Leggio B, Scheggi S, Tagliamonte A, De Montis MG, Gambarana C. 2002. Effects of long-term acetyl-L-carnitine administration in rats: I. increased dopamine output in mesocorticolimbic areas and protection toward acute stress exposure. Neuropsychopharmacology. 27:410–420.
   PubMed Web of Science ®Google Scholar
• Virmani A, Ali SF, Binienda ZK. 2010. Neuroprotective strategies in drug abuse-evoked encephalopathy. Ann N Y Acad Sci. 1199:52–68.
   PubMed Web of Science ®Google Scholar
• Weiss RB, Stange JP, Boland EM, Black SK, LaBelle DR, Abramson LY, Alloy LB. 2015. Kindling of life stress in bipolar disorder: comparison of sensitization and autonomy models. J Abnorm Psychol. 124:4–16.
   PubMed Web of Science ®Google Scholar